← Evidence map

ArticlePsychopharmacology2026

Response to Barner et al. (2025) on comment on Zabik et al. (2024): special considerations for cannabis research in RCTs and feasibility in a clinical setting.

Joshua AviramPubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40815407